FDA CONSUMER HEALTH INFORMATION - July 13 Webinar: FDA's Safety Monitoring of Approved Vaccines

Thursday, July 8, 2010 General News J E 4

SILVER SPRING, Md., July 8 /PRNewswire-USNewswire/ -- Did you know the Food and Drug Administration (FDA) continues to review vaccine safety even after a vaccine is approved?



Learn more when FDA's Center for Biologics Evaluation and Research hosts a 30-minute webinar on the agency's efforts to ensure the safety of vaccines.

During the webinar, FDA will give an overview of vaccine safety surveillance, including the Vaccine Adverse Event Reporting System (VAERS) and efforts underway to improve safety monitoring. FDA is working with federal, international, academic, and health care partners to improve its ability to evaluate the safety of vaccines.

There will be an opportunity to ask questions following the presentation.

When:  Tuesday, July 13, 2010, at 2:00 p.m. EDT

Where: To join the webinar, see the instructions at Webinar materials will also be available there.

Host:  FDA's Center for Biologics Evaluation and Research

phone: 1-800-835-4709


Featured speaker: Andrea Sutherland, M.D., M.P.H., M.Sc., is a medical officer and special assistant to the director of the Division of Epidemiology in the Office of Biostatistics and Epidemiology within FDA's Center for Biologics Evaluation and Research.

This webinar is the sixth in a series of monthly online sessions hosted by different FDA centers and offices. The series is part of FDA Basics, a Web-based resource aimed at helping the public better understand what the agency does.

Find out more about FDA's role in regulating vaccines at

Sign up for e-mail notices of new FDA Consumer Updates at:

View the FDA Consumer Update RSS feed at:

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to:

Media Contact: Jason Brodsky at 301-796-8234;

SOURCE U.S. Food and Drug Administration



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Mintel Presents Latest Food and Drink Trends and I...
dLife Continues to Dominate Among the Diabetes Com...